These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28569364)

  • 21. Serum thyroglobulin in the management of patients with thyroid cancer.
    Barsano CP; Skosey C; DeGroot LJ; Refetoff S
    Arch Intern Med; 1982 Apr; 142(4):763-7. PubMed ID: 7073416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [131I-accumulating pulmonary and bone metastases of differentiated thyroid cancer with low serum thyroglobulin levels--an exception in tumor follow-up?].
    Arning G; Ehrenheim C; Schober O; Hundeshagen H
    Nuklearmedizin; 1987 Jun; 26(3):139-42. PubMed ID: 3628022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal.
    Oyen WJ; Verhagen C; Saris E; van den Broek WJ; Pieters GF; Corsten FH
    J Nucl Med; 2000 Apr; 41(4):643-6. PubMed ID: 10768565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases.
    Ma C; Kuang A; Xie J
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD006988. PubMed ID: 19160311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroglobulin measurement and postablative iodine-131 total body scan after total thyroidectomy for differentiated thyroid carcinoma in patients with no evidence of disease.
    Tenenbaum F; Corone C; Schlumberger M; Parmentier C
    Eur J Cancer; 1996 Jun; 32A(7):1262. PubMed ID: 8758265
    [No Abstract]   [Full Text] [Related]  

  • 27. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer.
    Orlov S; Salari F; Kashat L; Freeman JL; Vescan A; Witterick IJ; Walfish PG
    Endocrine; 2015 Sep; 50(1):130-7. PubMed ID: 25792004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan.
    Kim WG; Ryu JS; Kim EY; Lee JH; Baek JH; Yoon JH; Hong SJ; Kim ES; Kim TY; Kim WB; Shong YK
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1169-73. PubMed ID: 20080852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advances in Diagnosis and Treatment of Differentiated Thyroid Cancer in Patients Showing Thyroglobulin Elevative and Iodine Scintigraphy Negative].
    Ma N; Li S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Jun; 32(3):707-11. PubMed ID: 26486005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can thyroglobulin assay really supplant radioiodine scans in patients with differentiated thyroid cancer?
    Castagnoli A; Cappelli G; D'Agata A; Forni S; Milani S; Pupi A
    Lancet; 1982 Mar; 1(8271):573-4. PubMed ID: 6120429
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan.
    Chao M
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):438-47. PubMed ID: 20561773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thyroid cancer: metabolic treatment and follow-up using thyroglobulin levels and I-131 gammagraphy].
    Lampreave JL; Trampal C; Domínguez P; Bittini A
    Rev Clin Esp; 1998 May; 198(5):307-15. PubMed ID: 9658914
    [No Abstract]   [Full Text] [Related]  

  • 34. 30mCi radioactive iodine achieving comparative excellent response in intermediate/high-risk nonmetastatic papillary thyroid cancer: a propensity score matching study.
    Zhang Y; Wang C; Zhang X; Li H; Li X; Lin Y
    Endocrine; 2018 Dec; 62(3):655-662. PubMed ID: 30145748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A low thyroglobulin level cannot be used to avoid adjuvant 131I therapy after thyroidectomy for thyroid carcinoma.
    Zanotti-Fregonara P; Grassetto G; Hindié E; Rubello D
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):169-71. PubMed ID: 18850097
    [No Abstract]   [Full Text] [Related]  

  • 36. Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma.
    Zerva B; Koutsikos J; Palestidis C; Kounadi E; Gerali S
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):348-54. PubMed ID: 17043633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum thyroglobulin in the management of thyroid cancer.
    Blahd WH
    J Nucl Med; 1990 Nov; 31(11):1771-3. PubMed ID: 2121914
    [No Abstract]   [Full Text] [Related]  

  • 39. Elevated serum thyroglobulin levels at the time of ablative radioactive iodine therapy indicate a worse prognosis in thyroid cancer: an Australian retrospective cohort study.
    Matthews TJ; Chua E; Gargya A; Clark J; Gao K; Elliott M
    J Laryngol Otol; 2016 Jul; 130 Suppl 4():S50-3. PubMed ID: 27488338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma.
    Dadparvar S; Krishna L; Brady LW; Slizofski WJ; Brown SJ; Chevres A; Micaily B
    Cancer; 1993 Jun; 71(11):3767-73. PubMed ID: 8490927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.